- Home
- CRDF vs ECBK Comparison
CRDF vs ECBK Comparison
Compare CRDF & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- ECBK
- Stock Information
- Founded
- CRDF 1999
- ECBK 1919
- Country
- CRDF United States
- ECBK United States
- Employees
- CRDF N/A
- ECBK N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- ECBK Banks
- Sector
- CRDF Health Care
- ECBK Finance
- Exchange
- CRDF Nasdaq
- ECBK Nasdaq
- Market Cap
- CRDF 143.4M
- ECBK 123.9M
- IPO Year
- CRDF N/A
- ECBK N/A
- Fundamental
- Price
- CRDF $2.58
- ECBK $15.00
- Analyst Decision
- CRDF Strong Buy
- ECBK
- Analyst Count
- CRDF 3
- ECBK 0
- Target Price
- CRDF $9.33
- ECBK N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- ECBK 7.3K
- Earning Date
- CRDF 11-07-2024
- ECBK 10-24-2024
- Dividend Yield
- CRDF N/A
- ECBK N/A
- EPS Growth
- CRDF N/A
- ECBK N/A
- EPS
- CRDF N/A
- ECBK 0.39
- Revenue
- CRDF $688,000.00
- ECBK $24,711,000.00
- Revenue This Year
- CRDF $15.00
- ECBK N/A
- Revenue Next Year
- CRDF N/A
- ECBK N/A
- P/E Ratio
- CRDF N/A
- ECBK $38.42
- Revenue Growth
- CRDF 49.57
- ECBK N/A
- 52 Week Low
- CRDF $1.07
- ECBK $11.30
- 52 Week High
- CRDF $6.42
- ECBK $15.68
- Technical
- Relative Strength Index (RSI)
- CRDF 41.24
- ECBK 52.94
- Support Level
- CRDF $2.85
- ECBK $14.90
- Resistance Level
- CRDF $4.38
- ECBK $15.65
- Average True Range (ATR)
- CRDF 0.45
- ECBK 0.23
- MACD
- CRDF -0.10
- ECBK -0.05
- Stochastic Oscillator
- CRDF 2.70
- ECBK 28.57
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.